title: Berberine-induced pigment dispersion in Bufo melanostictus melanophores by stimulation of beta-2 adrenergic receptors.
abstract: Reduced production of melanin by decreased or the absence of melanocytes leads to various hypopigmentation disorders, and the development of melanogenetic agents for photoprotection and hypopigmentation disorders is one of the top priority areas of research. Hence, the present study was carried out to elucidate the ability of berberine, a principal active ingredient present in the roots of the herb Berberis vulgaris to stimulate pigment dispersion in the isolated skin melanophores of the toad Bufo melanostictus. In the present study, mean melanophore size index of the isolated skin melanophores of B. melanostictus was assayed after treating with various concentrations of berberine. A marked melanin dispersion response leading to skin darkening was observed in the isolated melanophores of toad in response to berberine, which was found to be mediated through beta-2 adrenergic receptors. The physiologically significant dose-related melanin dispersion effects of berberine per se were found to be completely abolished by propranolol, which is a specific beta-2 adrenergic receptor blocker. These per se melanin dispersal effects were also found to be markedly potentiated by isoprenaline, which is a specific beta-adrenoceptor agonist. The results indicate that berberine causes a tremendous, dose-dependent, physiologically significant pigment dispersing in the isolated skin melanophores of B. melanostictus.
authors.affiliation: Department of Biotechnology, Saifia Science College , Bhopal, Madhya Pradesh , India.
authors.forename: Sharique A
authors.initials: SA
authors.lastname: Ali
authors.forename: Ishrat
authors.initials: I
authors.lastname: Naaz
authors.forename: Ram Kumar
authors.initials: RK
authors.lastname: Choudhary
mesh_terms: D000818:Animals; D001285:Atropine / Q000008:administration & dosage; D001599:Berberine / Q000008:administration & dosage*; D002025:Bufonidae; D008543:Melanins / Q000096:biosynthesis*; D008547:Melanophores / Q000187:drug effects / Q000378:metabolism; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D010859:Pigmentation Disorders; D018343:Receptors, Adrenergic, beta-2 / Q000096:biosynthesis* / Q000378:metabolism; D012601:Scopolamine / Q000008:administration & dosage; D014664:Vasodilation / Q000235:genetics*
chemical_list: D008543:Melanins; D018343:Receptors, Adrenergic, beta-2; D001599:Berberine; D001285:Atropine; D012601:Scopolamine; D010727:Phosphoric Diester Hydrolases